Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap 14,846 Cr
P/E 13.00
Div Yield 0.60 %
Book Value βΉ515.00
52w High βΉ1,227.00
52w Low βΉ789.00
Face Value βΉ2.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
735.00
739.00
647.00
1,363.00
1,329.00
1,221.00
475.00
1,371.00
1,363.00
1,068.00
759.00
1,031.00
1,140.00
Expenses
549.00
612.00
489.00
784.00
758.00
673.00
436.00
567.00
558.00
571.00
490.00
573.00
612.00
Operating Profit
186.00
128.00
159.00
579.00
571.00
548.00
39.00
804.00
805.00
497.00
268.00
458.00
528.00
OPM %
25.00
17.00
25.00
42.00
43.00
45.00
8.00
59.00
59.00
47.00
35.00
44.00
46.00
Other Income
59.00
78.00
58.00
100.00
62.00
66.00
176.00
64.00
48.00
42.00
37.00
29.00
20.00
Depreciation
47.00
50.00
46.00
52.00
58.00
98.00
47.00
46.00
44.00
56.00
44.00
44.00
44.00
Interest
13.00
11.00
10.00
13.00
3.00
10.00
4.00
4.00
5.00
6.00
5.00
4.00
4.00
Profit before tax
186.00
144.00
161.00
614.00
572.00
506.00
164.00
818.00
804.00
478.00
256.00
440.00
500.00
Tax %
34.00
-62.00
13.00
16.00
16.00
20.00
19.00
17.00
17.00
19.00
17.00
16.00
16.00
Net Profit
206.00
269.00
151.00
518.00
480.00
406.00
132.00
676.00
668.00
386.00
213.00
369.00
420.00
EPS in Rs
11.53
14.96
8.46
28.94
26.84
22.70
7.43
37.81
37.32
21.57
11.88
20.60
23.47
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
4,078.00 4,430.00 3,999.00 2,707.00 1,945.00 2,052.00 1,915.00 2,094.00 2,185.00 2,020.00 1,042.00 825.00
Expenses
2,642.00 2,234.00 2,245.00 1,772.00 1,681.00 1,446.00 1,332.00 1,300.00 1,256.00 1,337.00 777.00 615.00
Operating Profit
1,436.00 2,196.00 1,754.00 936.00 264.00 606.00 583.00 795.00 928.00 683.00 266.00 210.00
OPM %
35.00 50.00 44.00 35.00 14.00 30.00 30.00 38.00 42.00 34.00 25.00 25.00
Other Income
298.00 354.00 126.00 105.00 99.00 104.00 107.00 130.00 40.00 14.00 12.00 0.00
Interest
37.00 24.00 19.00 14.00 18.00 13.00 22.00 19.00 15.00 18.00 23.00 32.00
Depreciation
207.00 235.00 187.00 164.00 143.00 117.00 100.00 81.00 66.00 54.00 51.00 47.00
Profit before tax
1,491.00 2,291.00 1,674.00 862.00 202.00 580.00 569.00 825.00 887.00 624.00 204.00 132.00
Tax %
8.00 18.00 17.00 17.00 16.00 24.00 19.00 22.00 22.00 22.00 24.00 1.00
Net Profit
1,418.00 1,883.00 1,388.00 715.00 170.00 442.00 458.00 642.00 695.00 485.00 156.00 130.00
EPS in Rs
79.20 105.26 77.51 39.18 9.31 24.18 25.31 35.24 37.74 27.88 9.02 8.10
Dividend Payout %
6.00 6.00 12.00 14.00 48.00 22.00 27.00 18.00 22.00 24.00 14.00 12.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
36.00 36.00 36.00 36.00 36.00 36.00 36.00 36.00 37.00 35.00 35.00 33.00
Reserves
9,185.00 7,571.00 5,817.00 4,837.00 4,227.00 4,085.00 3,737.00 3,452.00 3,035.00 1,614.00 1,261.00 813.00
Borrowings
714.00 279.00 371.00 167.00 416.00 268.00 316.00 386.00 173.00 222.00 113.00 312.00
Other Liabilities
1,139.00 744.00 682.00 617.00 430.00 403.00 498.00 428.00 470.00 446.00 413.00 226.00
Total Liabilities
11,074.00 8,631.00 6,906.00 5,657.00 5,109.00 4,792.00 4,588.00 4,303.00 3,715.00 2,318.00 1,822.00 1,384.00
Fixed Assets
2,803.00 2,698.00 2,491.00 2,427.00 2,312.00 2,023.00 1,584.00 1,227.00 1,019.00 833.00 710.00 710.00
CWIP
294.00 225.00 137.00 64.00 130.00 223.00 518.00 638.00 480.00 336.00 212.00 129.00
Investments
3,127.00 474.00 539.00 392.00 308.00 304.00 112.00 169.00 76.00 32.00 22.00 2.00
Other Assets
4,850.00 5,234.00 3,739.00 2,774.00 2,360.00 2,242.00 2,373.00 2,270.00 2,140.00 1,116.00 878.00 543.00
Total Assets
11,074.00 8,631.00 6,906.00 5,657.00 5,109.00 4,792.00 4,588.00 4,303.00 3,715.00 2,318.00 1,822.00 1,384.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
1,768.00 1,697.00 1,212.00 849.00 46.00 299.00 417.00 669.00 464.00 346.00 112.00 93.00
Cash from Investing Activity
-2,082.00 -1,436.00 -1,026.00 -465.00 4.00 -107.00 -175.00 -611.00 -1,116.00 -299.00 -176.00 -120.00
Cash from Financing Activity
298.00 -211.00 -247.00 -363.00 35.00 -186.00 -251.00 -51.00 651.00 -48.00 154.00 29.00
Net Cash Flow
-16.00 50.00 -62.00 21.00 85.00 6.00 -8.00 7.00 -2.00 -1.00 90.00 2.00
Free Cash Flow
1,379.00 1,300.00 855.00 674.00 -142.00 92.00 81.00 225.00 57.00 66.00 -44.00 -25.00
CFO/OP %
151.00 94.00 85.00 110.00 36.00 71.00 90.00 107.00 72.00 69.00 60.00 55.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
79.00 103.00 109.00 115.00 116.00 73.00 105.00 88.00 106.00 86.00 92.00 85.00
Inventory Days
480.00 405.00 357.00 432.00 496.00 570.00 534.00 545.00 389.00 213.00 482.00 331.00
Days Payable
216.00 145.00 120.00 153.00 105.00 104.00 244.00 224.00 239.00 160.00 372.00 189.00
Cash Conversion Cycle
343.00 362.00 345.00 394.00 507.00 539.00 395.00 410.00 257.00 138.00 202.00 228.00
Working Capital Days
163.00 151.00 151.00 198.00 256.00 246.00 295.00 207.00 215.00 71.00 97.00 25.00
ROCE %
17.00 33.00 30.00 18.00 4.00 13.00 14.00 23.00 35.00 39.00 18.00 17.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
49.41
49.41
49.48
49.48
49.56
49.56
49.62
49.62
49.71
49.71
49.71
49.71
FIIs
16.99
17.37
15.16
14.09
15.52
17.49
17.94
17.51
17.45
16.14
13.72
12.82
DIIs
5.63
5.46
5.39
5.87
5.81
5.64
5.59
6.75
7.86
9.69
11.26
14.01
Public
27.97
27.74
29.97
30.56
29.12
27.30
26.88
26.13
24.99
24.46
25.32
23.48
No. of Shareholders
403,166
410,970
424,167
419,699
429,434
405,222
345,332
302,944
251,485
228,467
207,571
163,753
Corporate Actions
50 records
Back to all stocks